Company Profile
Avidity Biosciences Stock Price, News & Analysis
- Ticker:
- RNA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Avidity Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
12.81 USD (-1.00%)
Close
Last updated: June 23, 2026 at 00:00
219.12M USD
Market cap
Why the stock is moving
RNA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Avidity Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Avidity Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Avidity Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Avidity Biosciences to Participate in Upcoming Investor Conference
Source: Avidity Biosciences
- 03
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
Source: Avidity Biosciences
- 04
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
Source: Avidity Biosciences
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Avidity Biosciences (RNA)?
Avidity Biosciences (RNA) most recently closed at 12.81 USD, a -1.00% move versus the previous session.
What is the market cap of Avidity Biosciences (RNA)?
Avidity Biosciences currently has a market capitalization of 219.12M USD on BioPharmSignal.
What does Avidity Biosciences do?
Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is RNA stock listed?
Avidity Biosciences (RNA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Avidity Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Avidity?
Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Avidity Biosciences targeting with Avidity?
Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Avidity Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.